Sugi Predict

Sugi Predict / Compounds / SCHEMBL1543548

SCHEMBL1543548

SCHEMBL1543548

COCCN(C)S(=O)(=O)Nc1cc(-c2ccc3ncc(=O)n(-c4cccc(C(F)(F)F)c4)c3c2)cnc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 8/20 0.44
▸ PIK3CG P48736 2/20 0.41
▸ PI4KA P42356 1/20 0.41
▸ AKT1 P31749 2/20 0.40
▸ SCN9A Q15858 1/20 0.40
▸ GRIN2B Q13224 6/20 0.40
▸ GRIN1 Q05586 5/20 0.40
▸ MTOR P42345 5/20 0.38
▸ PIK3CD O00329 1/20 0.37
▸ PIK3C2A O00443 1/20 0.37
▸ PIK3C2B O00750 1/20 0.37
▸ PIK3R1 P27986 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ PRKDC P78527 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ ATR Q13535 1/20 0.37
▸ RPTOR Q8N122 1/20 0.37
▸ PIK3C3 Q8NEB9 1/20 0.37
▸ MLST8 Q9BVC4 1/20 0.37
▸ MKNK2 Q9HBH9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1543464 0.90 PIK3CA (0.46) PIK3CAPIK3CGPI4KAPIK3CDPIK3CB
SCHEMBL1543748 0.89 PIK3CA (0.46) PIK3CAPIK3CGPI4KAAKT1SCN9A
SCHEMBL8003919 0.81 MTOR (0.45) PIK3CAPIK3CGPI4KAAKT1SCN9A
SCHEMBL1543488 0.73 PIK3CA (0.42) PIK3CAAKT1MTORPIK3CDPIK3R1
SCHEMBL1543371 0.70 PIK3CA (0.57) PIK3CAPIK3CGMTORPIK3CDPIK3CB
SCHEMBL1543469 0.67 PIK3CA (0.63) PIK3CAPIK3CGMTORPIK3CDPIK3CB
SCHEMBL1544659 0.65 MTOR (0.45) PIK3CAPIK3CGMTORPIK3CDPIK3C2A
SCHEMBL1543605 0.65 PIK3CA (0.52) PIK3CAPIK3CGMTORPIK3CDPIK3CB
SCHEMBL3768508 0.61 PIK3CD (0.73) PIK3CAPIK3CGAKT1MTORPIK3CD
SCHEMBL1543786 0.61 PIK3CA (1.00) PIK3CAPIK3CGMTORPIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110092504-A1 INHIBITORS OF PI3 KINASE AMGEN INC. 2011-04-21 — — US claimed
EP-2307400-A2 INHIBITORS OF PI3 KINASE Amgen, Inc (US) 2011-04-13 — — EP claimed
WO-2009155121-A2 INHIBITORS OF PI3 KINASE AMGEN INC. (US) 2009-12-23 — — WO claimed
EP-2307400-B1 INHIBITORS OF PI3 KINASE AMGEN INC (US) 2014-04-23 — — EP disclosed
US-8415376-B2 Inhibitors of PI3 kinase AMGEN INC. (US) 2013-04-09 — — US disclosed
US-8415376-B2 Inhibitors of PI3 kinase AMGEN INC. (US) 2013-04-09 — — US disclosed
US-8415376-B2 Inhibitors of PI3 kinase AMGEN INC. (US) 2013-04-09 — — US disclosed
US-20110092504-A1 INHIBITORS OF PI3 KINASE AMGEN INC. 2011-04-21 — — US disclosed
US-20110092504-A1 INHIBITORS OF PI3 KINASE AMGEN INC. 2011-04-21 — — US disclosed
US-20110092504-A1 INHIBITORS OF PI3 KINASE AMGEN INC. 2011-04-21 — — US disclosed
EP-2307400-A2 INHIBITORS OF PI3 KINASE Amgen, Inc (US) 2011-04-13 — — EP disclosed
WO-2009155121-A2 INHIBITORS OF PI3 KINASE AMGEN INC. (US) 2009-12-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092504-A1 INHIBITORS OF PI3 KINASE PIK3CA, PIK3R1, PIK3R5 PIK3CA 1/4885PIK3CG 7/4885PI4KA 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.